Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Assets Average (2020 - 2025)

Historic Assets Average for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to $2.1 million.

  • BioScience Health Innovations' Assets Average rose 55528.17% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 55528.17%. This contributed to the annual value of $483588.0 for FY2024, which is 67376.56% up from last year.
  • According to the latest figures from Q3 2025, BioScience Health Innovations' Assets Average is $2.1 million, which was up 55528.17% from $1.7 million recorded in Q2 2025.
  • BioScience Health Innovations' Assets Average's 5-year high stood at $2.1 million during Q3 2025, with a 5-year trough of $1378.5 in Q2 2021.
  • Moreover, its 5-year median value for Assets Average was $78984.0 (2023), whereas its average is $351474.2.
  • As far as peak fluctuations go, BioScience Health Innovations' Assets Average crashed by 9105.25% in 2021, and later soared by 336619.51% in 2022.
  • Over the past 5 years, BioScience Health Innovations' Assets Average (Quarter) stood at $51224.0 in 2021, then plummeted by 56.47% to $22298.0 in 2022, then surged by 322.43% to $94194.5 in 2023, then soared by 584.55% to $644809.0 in 2024, then soared by 219.82% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q3 2025, $1.7 million for Q2 2025, and $1.1 million during Q1 2025.